Tag: left atrial appendage closure
Left atrial appendage closure associated with a decreased stroke risk in...
Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...
SentreHeart announces initial clinical use of the Lariat with EpiRail procedure...
SentreHeart recently announced it has successfully completed nine first-in-human procedures utilising the Lariat with EpiRail at John Paul II hospital in Krakow, Poland. The...
Short-term DAPT is feasible for patients undergoing percutaneous LAA closure
Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...
SentreHEART Lariat and Eclipse receive reimbursement renewal in Germany
The German Institute for the Hospital Remuneration System (InEK) has renewed Status 1—the highest of four levels—for SentreHEART’s Lariat and Eclipse left atrial appendage...
SentreHEART announces first clinical use of the Eclipse surgical left atrial...
SentreHEART has announced it has treated the first patients using the Eclipse surgical device for left atrial appendage (LAA) closure. Krzysztof Bartus (Jagiellonian University,...